https://orcid.org/0000-0002-1832-3209
Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Béatrice Laupèze, Ventzislav Vassilev & Selim Badur. (2023) A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments. Expert Review of Gastroenterology & Hepatology 17:11, pages 1135-1147.
Read now
Read now
Articles from other publishers (7)
Yu-Long Fu, Shuang-Nan Zhou, Wei Hu, Jing Li, Ming-Ju Zhou, Xiao-Yu Li, You-Yuan Wang, Peng Zhang, Si-Yuan Chen, Xing Fan, Jin-Wen Song, Yan-Mei Jiao, Ruonan Xu, Ji-Yuan Zhang, Cheng Zhen, Chun-Bao Zhou, Jin-Hong Yuan, Ming Shi, Fu-Sheng Wang & Chao Zhang. (2023) Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B. Hepatology International.
Crossref
Crossref
Dmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, Natalia Ponomareva, Natalia F. Zakirova, Aleksandra Egorshina, Dmitry V. Yanvarev, Ekaterina Bayurova, Anna Sudina, Irina Goptar, Anastasiya Nikiforova, Elena Dunaeva, Tatiana Lisitsa, Ivan Abramov, Anastasiia Frolova, Alexander Lukashev, Ilya Gordeychuk, Andrey A. ZamyatninJr.Jr., Alexander Ivanov & Vladimir Chulanov. (2023) Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9. Molecular Therapy - Nucleic Acids 31, pages 482-493.
Crossref
Crossref
Wenhui Tu, Jin Liu, Feng Qian, Li Zhu, Ming Li, Hui Zheng & Chuanwu Zhu. (2023) Ubiquitin E3 ligase β‐TrCP negatively regulates surface protein of hepatitis B virus. Journal of Medical Virology 95:3.
Crossref
Crossref
Claudia Giordano, Marco Picardi, Novella Pugliese, Annamaria Vincenzi, Davide Pio Abagnale, Laura De Fazio, Maria Luisa Giannattasio, Carmina Fatigati, Mauro Ciriello, Alessia Salemme, Giada Muccioli Casadei, Elena Vigliar, Massimo Mascolo, Giancarlo Troncone & Fabrizio Pane. (2023) Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21. Frontiers in Oncology 13.
Crossref
Crossref
S. A. Brezgin, A. P. Kostyusheva, N. I. Ponomareva, V. I. Gegechkori, N. P. Kirdyashkina, S. R. Ayvasyan, L. N. Dmitrieva, L. N. Kokoreva, V. P. Chulanov & D. S. Kostyushev. (2022) HBx Protein Potentiates Hepatitis B Virus Reactivation. Molecular Biology 56:5, pages 713-722.
Crossref
Crossref
Louis Sandra, Huybrecht T’jollyn, Nele Goeyvaerts, An Vermeulen, Anne-Gaëlle Dosne & Juan-Jose Perez-Ruixo. (2022) Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated–Hepatitis B Virus–Infected Mice. Journal of Pharmacology and Experimental Therapeutics 383:1, pages 70-79.
Crossref
Crossref
Vladimir Chulanov, Anastasiya Kostyusheva, Sergey Brezgin, Natalia Ponomareva, Vladimir Gegechkori, Elena Volchkova, Nikolay Pimenov & Dmitry Kostyushev. (2021) CRISPR Screening: Molecular Tools for Studying Virus–Host Interactions. Viruses 13:11, pages 2258.
Crossref
Crossref